23 research outputs found
Recent insights into the complexity of Tank-binding kinase 1 signaling networks: The emerging role of cellular localization in the activation and substrate specificity of TBK1
AbstractTank-binding kinase 1 (TBK1) serves as an important component of multiple signaling pathways. While the majority of research on TBK1 has focused on its role in innate immunity, critical functions for TBK1 in autophagy and cancer are beginning to emerge. This review highlights recent structural and biochemical studies that provide insights into the molecular mechanism of TBK1 activation and summarizes what is known to date about TBK1 substrate selection. Growing evidence suggests that both processes rely on TBK1 subcellular localization, with a variety of adaptor proteins each directing TBK1 to discrete signaling complexes for different cellular responses. Further study of TBK1-mediated pathways will require careful consideration of TBK1 mechanisms of activation and specificity for proper dissection of these distinct signaling cascades
Prognosis of neonatal tetanus in the modern management era: an observational study in 107 Vietnamese infants.
OBJECTIVES: Most data regarding the prognosis in neonatal tetanus originate from regions where limited resources have historically impeded management. It is not known whether recent improvements in critical care facilities in many low- and middle-income countries have affected indicators of a poor prognosis in neonatal tetanus. We aimed to determine the factors associated with worse outcomes in a Vietnamese hospital with neonatal intensive care facilities. METHODS: Data were collected from 107 cases of neonatal tetanus. Clinical features on admission were analyzed against mortality and a combined endpoint of 'death or prolonged hospital stay'. RESULTS: Multivariable analysis showed that only younger age (odds ratio (OR) for mortality 0.69, 95% confidence interval (CI) 0.48-0.98) and lower weight (OR for mortality 0.06, 95% CI 0.01-0.54) were significantly associated with both the combined endpoint and death. A shorter period of onset (OR 0.94, 95% CI 0.88-0.99), raised white cell count (OR 1.17, 95% CI 1.02-1.35), and time between first symptom and admission (OR 3.77, 95% CI 1.14-12.51) were also indicators of mortality. CONCLUSIONS: Risk factors for a poor outcome in neonatal tetanus in a setting with critical care facilities include younger age, lower weight, delay in admission, and leukocytosis
Recommended from our members
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation
Many cancers evade immune rejection by suppressing major histocompatibility class I (MHC-I) antigen processing and presentation (AgPP). Such cancers do not respond to immune checkpoint inhibitor therapies (ICIT) such as PD-1/PD-L1 [PD-(L)1] blockade. Certain chemotherapeutic drugs augment tumor control by PD-(L)1 inhibitors through potentiation of T-cell priming but whether and how chemotherapy enhances MHC-I-dependent cancer cell recognition by cytotoxic T cells (CTLs) is not entirely clear. We now show that the lysine acetyl transferases p300/CREB binding protein (CBP) control MHC-I AgPPM expression and neoantigen amounts in human cancers. Moreover, we found that two distinct DNA damaging drugs, the platinoid oxaliplatin and the topoisomerase inhibitor mitoxantrone, strongly up-regulate MHC-I AgPP in a manner dependent on activation of nuclear factor kappa B (NF-κB), p300/CBP, and other transcription factors, but independently of autocrine IFNγ signaling. Accordingly, NF-κB and p300 ablations prevent chemotherapy-induced MHC-I AgPP and abrogate rejection of low MHC-I-expressing tumors by reinvigorated CD8+ CTLs. Drugs like oxaliplatin and mitoxantrone may be used to overcome resistance to PD-(L)1 inhibitors in tumors that had "epigenetically down-regulated," but had not permanently lost MHC-I AgPP activity
Analysis of prerequisites violations financial stability
Світова економічна криза 2007–2008 років і потрясіння, що охо-
пили одночасно секторальні ринки кредитування, страхування, нерухомості та цінних паперів, продемонстрували, що системні ризики
підтримки фінансової стабільності не були належним чином оцінені
регуляторами
Complementary Proteomic Tools for the Dissection of Apoptotic Proteolysis Events
Proteolysis is a key regulatory event that controls intracellular
and extracellular signaling through irreversible changes in a protein’s
structure that greatly alters its function. Here we describe a platform
for profiling caspase substrates which encompasses two highly complementary
proteomic techniquesthe first is a differential gel based
approach termed Global Analyzer of SILAC-derived Substrates of Proteolysis
(GASSP) and the second involves affinity enrichment of peptides containing
a C-terminal aspartic acid residue. In combination, these techniques
have enabled the profiling of a large cellular pool of apoptotic-mediated
proteolytic events across a wide dynamic range. By applying this integrated
proteomic work flow to analyze proteolytic events resulting from the
induction of intrinsic apoptosis in Jurkat cells via etoposide treatment,
3346 proteins were quantified, of which 360 proteins were identified
as etoposide-induced proteolytic substrates, including 160 previously
assigned caspase substrates. In addition to global profiling, a targeted
approach using BAX HCT116 isogenic cell lines was utilized to dissect
pre- and post-mitochondrial extrinsic apoptotic cleavage events. By
employing apoptotic activation with a pro-apoptotic receptor agonist
(PARA), a limited set of apoptotic substrates including known caspase
substrates such as BH3 interacting-domain death agonist (BID) and
Poly (ADP-ribose) polymerase (PARP)-1, and novel substrates such as
Basic Transcription Factor 3, TRK-fused gene protein (TFG), and p62/Sequestosome
were also identified
Complementary Proteomic Tools for the Dissection of Apoptotic Proteolysis Events
Proteolysis is a key regulatory event that controls intracellular
and extracellular signaling through irreversible changes in a protein’s
structure that greatly alters its function. Here we describe a platform
for profiling caspase substrates which encompasses two highly complementary
proteomic techniquesthe first is a differential gel based
approach termed Global Analyzer of SILAC-derived Substrates of Proteolysis
(GASSP) and the second involves affinity enrichment of peptides containing
a C-terminal aspartic acid residue. In combination, these techniques
have enabled the profiling of a large cellular pool of apoptotic-mediated
proteolytic events across a wide dynamic range. By applying this integrated
proteomic work flow to analyze proteolytic events resulting from the
induction of intrinsic apoptosis in Jurkat cells via etoposide treatment,
3346 proteins were quantified, of which 360 proteins were identified
as etoposide-induced proteolytic substrates, including 160 previously
assigned caspase substrates. In addition to global profiling, a targeted
approach using BAX HCT116 isogenic cell lines was utilized to dissect
pre- and post-mitochondrial extrinsic apoptotic cleavage events. By
employing apoptotic activation with a pro-apoptotic receptor agonist
(PARA), a limited set of apoptotic substrates including known caspase
substrates such as BH3 interacting-domain death agonist (BID) and
Poly (ADP-ribose) polymerase (PARP)-1, and novel substrates such as
Basic Transcription Factor 3, TRK-fused gene protein (TFG), and p62/Sequestosome
were also identified
Complementary Proteomic Tools for the Dissection of Apoptotic Proteolysis Events
Proteolysis is a key regulatory event that controls intracellular
and extracellular signaling through irreversible changes in a protein’s
structure that greatly alters its function. Here we describe a platform
for profiling caspase substrates which encompasses two highly complementary
proteomic techniquesthe first is a differential gel based
approach termed Global Analyzer of SILAC-derived Substrates of Proteolysis
(GASSP) and the second involves affinity enrichment of peptides containing
a C-terminal aspartic acid residue. In combination, these techniques
have enabled the profiling of a large cellular pool of apoptotic-mediated
proteolytic events across a wide dynamic range. By applying this integrated
proteomic work flow to analyze proteolytic events resulting from the
induction of intrinsic apoptosis in Jurkat cells via etoposide treatment,
3346 proteins were quantified, of which 360 proteins were identified
as etoposide-induced proteolytic substrates, including 160 previously
assigned caspase substrates. In addition to global profiling, a targeted
approach using BAX HCT116 isogenic cell lines was utilized to dissect
pre- and post-mitochondrial extrinsic apoptotic cleavage events. By
employing apoptotic activation with a pro-apoptotic receptor agonist
(PARA), a limited set of apoptotic substrates including known caspase
substrates such as BH3 interacting-domain death agonist (BID) and
Poly (ADP-ribose) polymerase (PARP)-1, and novel substrates such as
Basic Transcription Factor 3, TRK-fused gene protein (TFG), and p62/Sequestosome
were also identified